HAROLD E. SELICK

Insider Reports History

Location
Newark, CA
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Harold E. Selick
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by HAROLD E. SELICK:

Company Role Class Num Shares Value Price $ Report Date Ownership
Protagonist Therapeutics, Inc Director Common Stock 60,845 $256,157 $4.21 09 Jan 2026 Direct
Molecular Templates, Inc. Director Stock Option (right to buy) 1,000 27 Sep 2024 Direct
Protagonist Therapeutics, Inc Director Stock Option (right to buy) 0 09 Jan 2026 Direct

Insider Reports Filed by HAROLD E. SELICK

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PTGX Protagonist Therapeutics, Inc 09 Jan 2026 2 +$60,199 4 Director 13 Jan 2026, 16:45
PTGX Protagonist Therapeutics, Inc 02 Jan 2026 2 $0 4 Director 06 Jan 2026, 19:44
PTGX Protagonist Therapeutics, Inc 28 Apr 2025 2 +$12,441 4 Director 30 Apr 2025, 16:45
PTGX Protagonist Therapeutics, Inc 02 Jan 2025 2 $0 4 Director 06 Jan 2025, 18:08
/report/000095017024110457-selick-harold-e-2024-09-27 Molecular Templates, Inc. 27 Sep 2024 1 $0 4 Director 30 Sep 2024, 17:36
PTGX Protagonist Therapeutics, Inc 07 Mar 2024 2 +$12,266 4 Director 11 Mar 2024, 20:00
PTGX Protagonist Therapeutics, Inc 02 Jan 2024 1 $0 4 Director 04 Jan 2024, 20:13
/report/000117184323006570-selick-harold-e-2023-10-27 Molecular Templates, Inc. 27 Oct 2023 1 $0 4 Director 31 Oct 2023, 18:46
PTGX Protagonist Therapeutics, Inc 10 Apr 2023 2 +$5,391 4 Director 11 Apr 2023, 19:18
PTGX Protagonist Therapeutics, Inc 16 Jan 2023 1 $0 4 Director 18 Jan 2023, 18:58
/report/000089924322021137-selick-harold-e-2022-06-03 Molecular Templates, Inc. 03 Jun 2022 1 $0 4 Director 06 Jun 2022, 07:30
PTGX Protagonist Therapeutics, Inc 26 May 2022 1 $0 4 Director 27 May 2022, 16:00
/report/000089924321022046-selick-harold-e-2021-06-03 Molecular Templates, Inc. 03 Jun 2021 1 $0 4 Director 04 Jun 2021, 16:30
PTGX Protagonist Therapeutics, Inc 27 May 2021 1 $0 4 Director 28 May 2021, 19:00